First Header Logo Second Header Logo

Connection

Walter Ambrosius to Angiotensin-Converting Enzyme Inhibitors

This is a "connection" page, showing publications Walter Ambrosius has written about Angiotensin-Converting Enzyme Inhibitors.
  1. Cauley JA, Manini TM, Lovato L, Talton J, Anton SD, Domanchuk K, Kennedy K, Stowe CL, Walkup M, Fielding RA, Kritchevsky SB, McDermott MM, Newman AB, Ambrosius WT, Pahor M. The Enabling Reduction of Low-Grade Inflammation in Seniors (ENRGISE) Pilot Study: Screening Methods and Recruitment Results. J Gerontol A Biol Sci Med Sci. 2019 07 12; 74(8):1296-1302.
    View in: PubMed
    Score: 0.160
  2. Shapiro BP, Ambrosius WT, Blackshear JL, Cushman WC, Whelton PK, Oparil S, Beddhu S, Dwyer JP, Gren LH, Kostis WJ, Lioudis M, Pisoni R, Rosendorff C, Haley WE. Impact of Intensive Versus Standard Blood Pressure Management by Tertiles of Blood Pressure in SPRINT (Systolic Blood Pressure Intervention Trial). Hypertension. 2018 06; 71(6):1064-1074.
    View in: PubMed
    Score: 0.147
  3. Ambrosius WT, Sink KM, Foy CG, Berlowitz DR, Cheung AK, Cushman WC, Fine LJ, Goff DC, Johnson KC, Killeen AA, Lewis CE, Oparil S, Reboussin DM, Rocco MV, Snyder JK, Williamson JD, Wright JT, Whelton PK. The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT). Clin Trials. 2014 Oct; 11(5):532-46.
    View in: PubMed
    Score: 0.112
  4. Goff DC, Massing MW, Bertoni AG, Davis J, Ambrosius WT, McArdle J, Duren-Winfield V, Sueta CA, Croft JB. Enhancing quality of heart failure care in managed Medicare and Medicaid in North Carolina: results of the North Carolina Achieving Cardiac Excellence (NC ACE) Project. Am Heart J. 2005 Oct; 150(4):717-24.
    View in: PubMed
    Score: 0.061
  5. Cesari M, Kritchevsky SB, Baumgartner RN, Atkinson HH, Penninx BW, Lenchik L, Palla SL, Ambrosius WT, Tracy RP, Pahor M. Sarcopenia, obesity, and inflammation--results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study. Am J Clin Nutr. 2005 Aug; 82(2):428-34.
    View in: PubMed
    Score: 0.061
  6. Carter CS, Cesari M, Ambrosius WT, Hu N, Diz D, Oden S, Sonntag WE, Pahor M. Angiotensin-converting enzyme inhibition, body composition, and physical performance in aged rats. J Gerontol A Biol Sci Med Sci. 2004 May; 59(5):416-23.
    View in: PubMed
    Score: 0.056
  7. Bertoni AG, Duren-Winfield V, Ambrosius WT, McArdle J, Sueta CA, Massing MW, Peacock S, Davis J, Croft JB, Goff DC. Quality of heart failure care in managed Medicare and Medicaid patients in North Carolina. Am J Cardiol. 2004 Mar 15; 93(6):714-8.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.